Thumbnail

دخول السوق - الصناعة المساعدة في البرازيل: تحليل النمو والاتجاهات والتقدم (2020-2025)

Looking to buy the report?

About the Market

Increase in the prevalence of cancer, growing reimbursement initiatives by governments and insurance companies covering treatment for cancer, with growth in preference for the future prevention of cancer are some of the major drivers of this market. The overall market for oncology adjuvants is classified on the basis of applications such as chemotherapy, radiotherapy, immunotherapy etc. By diseases which are treated through adjuvants, this market is classified into breast cancer, colorectal cancer, sarcoma, Hodgkin’s lymphoma, glioblastoma, lung cancer, prostate cancer, and ovarian cancer. North America, followed by Europe dominates the global market for breast cancer treatment, due to increasing incidence of cancer cases and technological advancement in the region. Some of the market players in this industry include pharmaceutical manufacturers such as Amgen Inc., Eli Lilly Co., BMS, Biogen, AstraZeneca PLC, Sanofi, and Pfizer Inc.

About the Geography

Brazil is the sixth largest economy in the world and by far the largest in South America. It has one of the world’s most rapidly developing economies and a GDP per head that is greater than India and China. Goldman Sachs reported that it has the potential to be one of the world’s most dominant economies by 2050.

The Brazilian government and the National Investment Bank (BNDES) encourage foreign investment. Most of the barriers to foreign investment have been removed and many public-sector companies have been privatized. The liberal policies of Brazil to foreign investment allow investors to have a majority share in the creation of their company. There are no restrictions on foreigners on buying land and commercial buildings. However, special authorization is required for sectors like nuclear, health, land ownership, fishing, aviation and highway freight. The government encourages foreign investment in the form of tax exemption, aid, etc. Tax reductions are granted to companies set up in economically disadvantaged regions such as the North, Nordeste, and the Amazonian regions.

Complex tax systems, organized crime in certain parts, and corruption have made Brazil a risky destination. Still, the large domestic market, easy access to raw materials, and its growing economy have made Brazil an attractive destination for investors.

 

Component Name

                        Unit

From Site

GDP

USD billion

1775

GDP Annual Growth Rate

%

-3.8

GDP Per Capita

USD

11159

Employment Rate

%

54.2

Wages

USD/Month

628.059

Inflation Rate

%

8.48

Consumer Price Index (CPI)

Index Points

4741

Interest Rate

%

14.25

Loans to Private Sector

USD million/billion

258741.07 million

Balance of Trade

USD million/billion

3803 million

Business Confidence

(No Units)

53.7

Manufacturing PMI

Index Points

46

Ease of Doing Business

(No Units)

116.00

Competitiveness Rank

(No Units)

81

Corruption Rank

(No Units)

76

Consumer Confidence

(No Units)

103

Consumer Spending

USD million/billion

299,828.56 million

Bank Lending Rate (Consumers)

%

71.85

Corporate Tax Rate

%

34

Sales Tax Rate

%

19

 

The Market Entry Series

Exploring global markets is now recognized as the shortest way to ensure high time to efficiency conversion, when trying to expand revenues past domestic markets, for firms both large and small. Our market entry series, priced suitably low contains the essentials of all the parameters (Refer: Table of Contents) you must be apprised of before you can have a well informed contemplation of a business opportunity in your choice of industry, in your choice of geography.

1. Introduction

                1.1 Scope of the Report

                1.2 Regional Analysis

                                1.2.1 PESTLE Analysis

                                1.2.2 Analysis of Ease of Doing Business

2. Market Dynamics

                2.1 Drivers

                2.2 Restraints

                2.3 Opportunities

3. Market Demand Analysis

                3.1 Socio-Economic Segmentation

                3.2 Demographic Strengths & Weaknesses

                3.3 Spending Patterns

                3.4 Target Market Identification

4. Market Size of Adjuvant Industry (USD millions)

                4.1 By Types of Inorganic Compounds

                4.2 By Bacterial Products

5. Market Entry

                5.1 Market Entry: The Strategy

                                5.1.1 Types of Entry Modes, by Market Entry Objectives

                                5.1.2 Competition Analysis

                                                5.1.2.1 Market Share

                                                5.1.2.2 Strategies Adopted, Recent Events 

                                5.1.3 Pricing Strategy

                                5.1.4 Supply Chain Analysis

                                                5.1.4.1 Trade (Import-Export Analysis)

                                                5.1.4.2 Distribution Network & Retail Analysis

                5.2 Market Entry: The Administration

                                5.2.1 How to Register a Company (Flowchart)

                                5.2.2 Registration Processes 

                                                5.2.2.1 Ministries Involved

                                                5.2.2.2 Criteria and Conditions

                                5.2.3 List of Forms & Documents

                                5.2.4 Product Control Guidelines specified by the Government

6. Sources

7. Disclaimer

Looking to buy the report?

Need a report that reflects how COVID-19 has impacted this market and its growth?

Looking to customize report?

Email

Message

By submitting, you confirm that you agree to our privacy policy